Announcement on the Start of Investigator-Initiated Clinical Trial of iPS cell-Derived Islet Cell Sheet Transplantation

Presenting at BIO International Convention 2024

Completion of Series B Funding Round

Orizuru x T-CiRA Cross Talk

Presenting at Biotech Showcase 2023

Orizuru Therapeutics Launches Operations as Research and Development-driven Company for Products Including induced Pluripotent Stem Cell (iPSC) Regenerative Medicine